59
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Study of Once-Daily Versus Twice-Daily Fosamprenavir plus Ritonavir Administered with Abacavir/Lamivudine Once Daily in Antiretroviral-Naïve HIV-1–Infected Adult Subjects

, , , , , , , , , , & show all
Pages 356-367 | Published online: 06 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Giuliano Rizzardini & Patrizia Zucchi. (2011) Abacavir and lamivudine for the treatment of human immunodeficiency virus. Expert Opinion on Pharmacotherapy 12:13, pages 2129-2138.
Read now

Articles from other publishers (10)

Masaaki Doi, Fumihiro Takahashi & Yohei Kawasaki. (2017) Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test. Statistics in Medicine 36:30, pages 4789-4803.
Crossref
Michael O'Kelly & Bohdana RatitchSara Hughes. 2014. Clinical Trials with Missing Data. Clinical Trials with Missing Data 36 52 .
Michael O'Kelly & Bohdana Ratitch. 2014. Clinical Trials with Missing Data. Clinical Trials with Missing Data 409 421 .
Suelen Jorge Souza, Liania Alves Luzia, Sigrid Sousa Santos & Patrícia Helen Carvalho Rondó. (2013) Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review. Revista da Associação Médica Brasileira 59:2, pages 186-198.
Crossref
Suelen Jorge Souza, Liania Alves Luzia, Sigrid Sousa Santos & Patrícia Helen Carvalho Rondó. (2013) Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review. Revista da Associação Médica Brasileira (English Edition) 59:2, pages 186-198.
Crossref
Sara Hughes, Julia Harris, Nancy Flack & Robert L. Cuffe. (2012) The statistician's role in the prevention of missing data. Pharmaceutical Statistics 11:5, pages 410-416.
Crossref
J. A. Perez-Molina, M. Diaz-Menendez, M. N. Plana, J. Zamora, R. Lopez-Velez & S. Moreno. (2011) Very late initiation of HAART impairs treatment response at 48 and 96 weeks: results from a meta-analysis of randomized clinical trials. Journal of Antimicrobial Chemotherapy 67:2, pages 312-321.
Crossref
Dushyantha T. Jayaweera & Gary E. Pakes. (2012) Virologic and Lipoprotein Changes after Halving Ritonavir Boosting in HIV-Infected Patients Stabilized on Once-Daily Fosamprenavir plus Abacavir/Lamivudine. World Journal of AIDS 02:02, pages 109-116.
Crossref
Nicolás MerchanteLuis F. López-CortésMarcial Delgado-FernándezMaria J. Ríos-VillegasManuel Márquez-SoleroDolores MerinoJuan PasquauCarolina García-FiguerasMaria Angeles Martínez-PérezMohamed OmarAntonio RiveroJuan MacíasRosario MataJuan Antonio Pineda, on behalf of the Grupo Anda. (2011) Liver Toxicity of Antiretroviral Combinations Including Fosamprenavir Plus Ritonavir 1400/100 mg Once Daily in HIV/Hepatitis C Virus-Coinfected Patients. AIDS Patient Care and STDs 25:7, pages 395-402.
Crossref
Robert L. Cuffe. (2011) The inclusion of historical control data may reduce the power of a confirmatory study. Statistics in Medicine 30:12, pages 1329-1338.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.